Ion Beam Applications SA (OTCMKTS:IOBCF – Get Free Report)’s stock price dropped 5.4% during trading on Monday . The stock traded as low as $17.50 and last traded at $17.50. 400 shares traded hands during mid-day trading, a decline of 50% from the average session volume of 804 shares. The stock had previously closed at $18.50.
Ion Beam Applications Stock Performance
The stock has a 50 day simple moving average of $18.51 and a 200 day simple moving average of $17.87.
Ion Beam Applications Company Profile
Ion Beam Applications (OTCMKTS: IOBCF) is a Belgium-based medical technology company specializing in the development and deployment of particle therapy solutions for cancer treatment. Founded in 1986 and headquartered in Louvain-la-Neuve, the company is best known for its Proteus® line of proton therapy systems, which are designed to deliver precise, high-energy particle beams that target tumors while sparing healthy tissue. IBA oversees the full project lifecycle, from system design and manufacturing to installation, commissioning, and ongoing service support.
In addition to its flagship proton therapy business, IBA operates a diversified portfolio of technologies for medical and industrial applications.
Further Reading
- Five stocks we like better than Ion Beam Applications
- Chips to Bots: Qualcomm’s Agentic AI Breakout
- Ciena Fell 40%—Now One Analyst Sees 50% Upside
- Energy Transfer Taps the AI Power Boom
- Viking’s Obesity Edge May Be Staying Power, Not Weight Loss
Receive News & Ratings for Ion Beam Applications Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ion Beam Applications and related companies with MarketBeat.com's FREE daily email newsletter.
